* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Supplementary Information
Gene therapy of the human retina wikipedia , lookup
Genetic engineering wikipedia , lookup
DNA damage theory of aging wikipedia , lookup
DNA supercoil wikipedia , lookup
Non-coding DNA wikipedia , lookup
Primary transcript wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Gene expression profiling wikipedia , lookup
SNP genotyping wikipedia , lookup
Cancer epigenetics wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Epigenomics wikipedia , lookup
Bisulfite sequencing wikipedia , lookup
Microevolution wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Designer baby wikipedia , lookup
Point mutation wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
Microsatellite wikipedia , lookup
Molecular cloning wikipedia , lookup
DNA vaccination wikipedia , lookup
Extrachromosomal DNA wikipedia , lookup
Helitron (biology) wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
History of genetic engineering wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Genomic library wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Supplementary Information A stereospecific solid phase screening assay expressing both (R)- and (S)-selective ω-aminotransferase. Simon C. Willies,a James L.Galman, a Iustina Slabua and Nicholas J. Turner a Plasmids, chemicals and strains All chemicals were reagent grade, purchased from Sigma-Aldrich (St Louis, MO, USA) and Fisher Scientific (Pittsburg, PA, USA), unless otherwise noted. Restriction enzymes, T4 ligase, and broad protein marker (2-212 kDa) E. coli DH5α and E. coli BL21 Star (DE3) were purchased from New England Biolabs (Ipswich, MA, USA). Primers were purchased from Eurofins MWG operon (Ebersberg, Germany) and Ni-NTA agarose were purchased from Invitrogen (Carlsbad, CA) and pET21a(+) (Novagen, Germany) were used for gene expression. The D-AAO gene was codon optimised for expression in E. coli and synthesised by Geneart AG with the restriction sites NcoI and NotI at the 5’ and 3’ ends respectively in the vector pMA. The D-AAO was excised from the vector using NcoI and NotI and inserted into pRSF-Duet using the same restriction sites, to create pRSF-D-AAO. The AlaR gene was cloned into pET16b as described elsewhere.1 The ATA-1172 and CV-ATA3 genes were obtained from Prof. Wolfgang Kroutil (University of Graz) in pET21a. Aminotransferase plasmid DNA (pLE1A17-ATA-50) was obtained from c-LEcta GmbH (Leipzig, Germany). Subcloning of wild-type aminotransferase (pLE1A17-ATA-50) The DNA sequence encoding aminotransferase (pLE1A17-ATA-50) was kindly provided by c-LEcta and was subcloned into a compatible vector suitable for heterologous protein expression in E.coli cells. The DNA insert and the vector backbone were assembled into DNA multimers via POE-PCR as described elsewhere.4 The DNA multimers were transformed into supercompetent E. coli DH5α cells and yielded pET21a-ATA-50. The plasmid was sequenced and verified by GATC Biotech AG (Konstanz, Germany). Cotransformation of D-AAO and ATA plasmids in E.coli BL21 (DE3) cells. Plasmids (D-AAO and ATA) were cotransformed in E. coli BL21 (DE3) cells and plated onto a Hybond-N membrane laid on LB/agar containing ampicillin (100 mg/mL) and kanamycin (50 mg/mL) and incubated at 30 °C overnight. The membrane was then transferred onto fresh LB/agar containing IPTG (0.2 mM) ampicillin (100 µg/mL) and kanamycin (50 µg/mL), and incubated for a further 18 h at 20 °C. The membrane was then placed at -20 °C overnight. To confirm the presence of the plasmids in E.coli cells, synthetic oligonucleotide primers were designed to anneal to the complementary DNA strand of pET21a-CV-ATA and pRSF-DAAO genes as an example. DAAO Rev: CAG ATT CGG ACG GGT CAG TGC (P1) DAAO Fw: GCC AAA ATT GTT GTT ATT GGT GC (P2) CV-ATA Fw: AGC GGC CAG AAA CAG CGT ACC ACC TC (P3) CV-ATA Rev: GGC CAG ACC ACG TGC TTT CAG (P4) 10 colonies were picked and a ‘colony PCR’ was performed using taq polymerase (NEB) (Table 1). All selected colonies confirmed the presence of both genes in the cell Fig.1. Cycle step Temp. Time Cycles Initial denaturation 95 °C 5 mins 1 Denaturation Annealing1 Extension2 95 °C 58 °C 68 °C 30 s 30 s 2 mins 30 cycles Final extension 72 °C 4 °C 10 min hold 1 Table 1: PCR cycles for colony PCR Fig 1: DNA gel of genes amplified in colony PCR; A) DNA ladder, B) CV-ATA gene amplification only using primers (P3/P4), C) DAAO gene amplification only using primers (P1/P2), D) Simultaneous CV-ATA and DAAO amplification using (P1/P2/P3/P4) in PCR mix. Coexpression and purification of heterologous protein DAAO and ATA The freshly-prepared strain E. coli BL21 (DE3) containing pET21a-ATA and pRSF-DAAO was cultivated in 600 mL of the LB medium supplemented with 50 µg/mL kanamycin and 100 µg/mL ampicillin in 1-L Erlenmeyer flasks at a rotary shaking rate of 250 rpm at 37 °C. The recombinant protein expression was induced by adding isopropyl β-D-1- thiogalactopyranoside (IPTG) (0.2 mM, final) when A600 reached 0.6 - 0.8. The cell cultures were incubated at 18 °C for 16 h. The cells were harvested by centrifugation at 4 °C, and resuspended in 20 mL of TRIS-HCl (pH 7.4) with 100 mM NaCl and 50 µM PLP. The cell pellets were lysed in an iced bath by ultra-sonication by Fisher Scientific Sonic Dismembrator Model 500 (3-s pulse, total 90 s, at 30% amplitude). After centrifugation at 4,000 rpm for 20 min, the lysate supernatant was loaded on a 20 mL column with a capped bottom outlet (purchased from BioRad, Munich) containing 1 mL of the 50 % Ni-NTA slurry. A 10 mL wash buffer containing 50 mM TRIS, 30 mM imidazole and 50 uM PLP at pH 7.4 was used to elute unbound proteins. The his-tag ATA-50 protein was eluted with 10 mL elution buffer containing 50mM TRIS, 300 mM imidazole, 100 mM NaCl and 50 uM PLP at pH 7.4 and then concentrated in a micropore filter. The fractions of unbound proteins from the flow-through and washing steps were collected and passed through a preequilibrated 1 mL strep-tactin column (IBA, Göttingen) and subsequently washed with 10 mL wash buffer containing 100 mM Tris, 150 mM NaCl, 1 mM EDTA at pH 8.0. The streptag D-AAO was eluted with the aforementioned buffered solution with additional 2.5 mM desthiobiotin and the purity of both purified proteins was analysed by SDS-PAGE which gave more than 95% purity (Figure 2). Figure 2: SDS gel of pRSF-DAAO and coexpressed pET21a-ATA-50 (gene provided by cLEcta) with pRSF-DAAO Solid phase screening for R-selective colonies A pre-screen solution containing horse radish peroxidase (0.1 mg/mL), pyruvate (0.2 mg/mL) and 50 mM potassium phosphate pH 8.0 was pre-soaked onto filter paper. The membrane was laid onto the filter paper and left at room temperature for 1 hour. The membrane was freeze-thawed with liquid nitrogen then transferred to a pre-soaked filter paper containing colorimetric assay solution: 1 x 3,3’-diaminobenzidine tablet (Sigma), 10mM substrate, horseradish peroxidase (0.1 mg/mL, Sigma) in 50 mM potassium phosphate pH 8.0. The membrane was left at room temperature and colour change is observed over time. Solid phase screening for S -selective colonies The (S)-selective solid phase screen is analogous to the (R)-selective screen with an additional prepared membrane containing alanine racemase (AlaR). A 5mL starter culture of Ala-pET16b in E. coli BL21 (DE3) was grown in LB media at 37 °C for 4 hours (OD ≈0.3). 300 μL of starter culture was plated onto an ampicillin (100 mg/mL) LB agar plate and grown at 30 °C overnight. The AlaR membrane was transferred onto fresh LB agar containing IPTG (0.2 mM) and ampicillin (100 mg/mL) and grown at 25 °C for four hours. The membrane was removed and freeze-thawed with liquid nitrogen. The membrane containing ATA-50/D-AAO colonies was laid onto AlaR membrane to produce a ‘sandwich’. The sandwich membranes are then transferred to the pre-screened and colorimetric assay soaked filter paper respectively. Hits were picked and sequenced to identify variants obtained. Library generation Mutagenesis libraries were generated using the Stratagene Quick-change™ site directed mutagenesis kit (stratagene). An NNS library was created in ATA-117 at amino acid position Phe116 (Figure 3) using the primers given in (Table 2). PCR conditions were as per the manufacturer’s instructions and parental DNA was removed by DpnI digestion for 2 hours at 37 °C. The PCR product was then transformed in E. coli XL-1 Blue, and 10 random colonies from the library were picked for sequencing to confirm library quality. All cells on the plate were resuspended in 5mL LB, centrifuged and DNA extracted to provide the mutant library. Primer Sequence ArR_116NNS_For AAA ACC GAA CTG CGT GAA GCA NNS GTT AGC GTT AGC ATT ACC CGT ArR_116NNS_Rev ACG GGT AAT GCT AAC GCT AAC SNN TGC TTC ACG CAG TTC GGT TTT Table 2. Mutagenic PCR Primers Figure 3. Enzyme binding site of ATA-117 Liquid phase assay A stock assay solution containing 10U D-AAO, 1 mg HRP, 2 mg pyruvate, 3mg 4aminoantipyrine (AAP), 2 mg 2,4,6-tribromo-3-hydroxybenzoic acid (TBHBA) all made up to 10 mL in 100mM HEPES pH8.0. Amine substrates were made to 200 mM in DMSO. Assays were carried out in 96 well MTP with 10 µL substrate/DMSO, 95 µL assay solution and 95 µL enzyme solution. Assays were monitored on a spectrophotometer at 510 nm and 30 °C for 30 minutes. 160 140 % Relative Activity 120 100 R-MBA 80 R-EBA 60 R-PBA 40 20 0 ArR116W _________ 1. S. C. Willies, J. L. White, and N. J. Turner, Tetrahedron, 2012, 68, 7564–7567. 2. C. K. Savile, J. M. Janey, E. C. Mundorff, J. C. Moore, S. Tam, W. R. Jarvis, J. C. Colbeck, A. Krebber, F. J. Fleitz, J. Brands, P. N. Devine, G. W. Huisman, and G. J. Hughes, Science, 2010, 329, 305–9. 3. U. Kaulmann, K. Smithies, M. E. B. Smith, H. C. Hailes, and J. M. Ward, Enzyme Microb. Technol., 2007, 41, 628–637. 4. C. You, X.-Z. Zhang, and Y.-H. P. Zhang, Appl. Environ. Microbiol., 2012, 78, 1593– 5.